IRIS
CASTRICONI, ROBERTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.874
AS - Asia 1.031
NA - Nord America 972
Continente sconosciuto - Info sul continente non disponibili 222
SA - Sud America 86
AF - Africa 23
OC - Oceania 3
Totale 11.211
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 8.680
US - Stati Uniti d'America 909
SG - Singapore 419
CN - Cina 254
VN - Vietnam 186
FR - Francia 69
BD - Bangladesh 64
BR - Brasile 49
HK - Hong Kong 40
FI - Finlandia 29
DE - Germania 28
CA - Canada 26
GB - Regno Unito 19
JP - Giappone 14
AR - Argentina 13
MX - Messico 12
IN - India 10
ID - Indonesia 8
NL - Olanda 8
HN - Honduras 7
CH - Svizzera 6
CL - Cile 5
CO - Colombia 5
EC - Ecuador 5
IQ - Iraq 5
ZA - Sudafrica 5
AL - Albania 4
ES - Italia 4
GT - Guatemala 4
MA - Marocco 4
PH - Filippine 4
PY - Paraguay 4
VE - Venezuela 4
AU - Australia 3
CR - Costa Rica 3
OM - Oman 3
PK - Pakistan 3
PL - Polonia 3
PT - Portogallo 3
RO - Romania 3
TR - Turchia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AT - Austria 2
BB - Barbados 2
DZ - Algeria 2
JO - Giordania 2
LT - Lituania 2
MY - Malesia 2
NI - Nicaragua 2
NP - Nepal 2
PR - Porto Rico 2
RU - Federazione Russa 2
SA - Arabia Saudita 2
TN - Tunisia 2
UA - Ucraina 2
BF - Burkina Faso 1
BO - Bolivia 1
BZ - Belize 1
CZ - Repubblica Ceca 1
DJ - Gibuti 1
DK - Danimarca 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
GP - Guadalupe 1
GR - Grecia 1
IE - Irlanda 1
JM - Giamaica 1
KE - Kenya 1
LB - Libano 1
LC - Santa Lucia 1
ME - Montenegro 1
MT - Malta 1
MU - Mauritius 1
NO - Norvegia 1
QA - Qatar 1
SE - Svezia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 10.989
Salva come PNG Salva come JPEG
Città #
Genova 5.089
Genoa 2.165
Rapallo 666
Vado Ligure 640
San Jose 278
Singapore 180
Ashburn 104
Lauterbourg 60
Ho Chi Minh City 58
Beijing 48
Council Bluffs 44
Hanoi 38
Hong Kong 36
New York 34
Helsinki 27
Santa Clara 27
Frankfurt am Main 25
Bordighera 24
Los Angeles 19
Chicago 15
Milan 12
Tokyo 12
Phoenix 11
Haiphong 10
Dallas 9
Rome 9
Da Nang 8
Buffalo 7
Mexico City 7
Naples 7
Orem 7
Tianjin 7
Washington 7
Amsterdam 6
San Francisco 6
São Paulo 6
Toronto 6
Zurich 6
Bologna 5
Des Moines 5
Jakarta 5
Philadelphia 5
Biên Hòa 4
City of London 4
Hải Dương 4
Johannesburg 4
Las Vegas 4
Miami 4
Paris 4
Queens 4
Thái Nguyên 4
Anaheim 3
Atlanta 3
Baghdad 3
Bari 3
Brooklyn 3
Cardiff 3
Charlotte 3
Columbus 3
Guatemala City 3
Manchester 3
Montreal 3
Newark 3
Ninh Bình 3
Palermo 3
Plano 3
Quảng Ngãi 3
Rio de Janeiro 3
San José 3
Sassari 3
Shanghai 3
Sydney 3
Tashkent 3
The Bronx 3
Amman 2
Arlington 2
Aurora 2
Barquisimeto 2
Billings 2
Boa Vista 2
Boardman 2
Bogotá 2
Boston 2
Boydton 2
Bra 2
Bridgetown 2
Brugnera 2
Buenos Aires 2
Calabash 2
Calgary 2
Can Tho 2
Cao Lanh 2
Changsha 2
Dubai 2
Figino 2
Florence 2
Fort Worth 2
Hornell 2
Houston 2
Jacksonville 2
Totale 9.897
Salva come PNG Salva come JPEG
Nome #
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance 249
PVR(CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis 243
Main NK cell receptors and their ligands: regulation by microRNAs 231
NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27 228
Natural Killer Cells and Neuroblastoma: Tumor Recognition, Escape Mechanisms, and Possible Novel Immunotherapeutic Approaches. 220
Both CD133(+) and CD133(-) medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity 216
M-CSF induces the expression of a membrane-bound form of IL-18 in a subset of human monocytes differentiating in vitro toward macrophages 206
Analysis of the molecular mechanism involved in 2B4-mediated NK cell activation: evidence that human 2B4 is physically and functionally associated with the linker for activation of T cells 192
Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells 191
Function and specificity of human natural killer cell receptors. 189
Human NK cell infusions prolong survival of metastatic human neuroblastoma-bearing NOD/scid mice. 187
The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes. 187
Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction 183
Cell-laden hydrogel as a clinical-relevant 3D model for analyzing neuroblastoma growth, immunophenotype, and susceptibility to therapies 182
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy? 179
Identification of NKp80, a novel triggering molecule expressed by human NK cells. 178
Molecular mechanisms directing migration and retention of natural killer cells in human tissues 178
Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors 175
CIS is a negative regulator of IL-15-mediated signals in NK cells 175
Human NK cells and NK receptors 173
Cellular ligands for activating NK receptors 169
Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface molecule. 168
Overview of the Soluble and Membrane-bound Tumor Factors Limiting NKmediated Immune Surveillance 168
CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity 167
Natural killer lymphocytes: "null cells" no more. 161
Novel Immunoregulatory Functions of IL-18, an Accomplice of TGF-β1 160
Imatinib and nilotinib off-target effects on human NK cells, monocytes, and M2 macrophages 160
Expression of the DNAM-1 ligands Nectin-2 (CD112) and poliovirus receptor (CD155) on dendritic cells: relevance for natural killer/dendritic cells interaction 160
Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. 156
Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines 155
Neuroblastoma-derived transforming growth factor (TGF) β1 modulates the chemokine receptor repertoire of human resting Natural Killer Cells. 153
Pathogen-induced private conversations between natural killer and dendritic cells 152
TGF-beta1 downregulates the expression of CX3CR1 by inducing miR-27a-5p in primary human NK cells 152
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance 151
TLR activation of tumor-associated macrophages from ovarian cancer patients triggers cytolytic activity of NK cells. 149
Cytokine-induced expression of killer inhibitory receptors in human T lymphocytes 147
Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine and chemokine secretion in CD56bright and CD56dim NK cells. 147
Immunotherapy in the Treatment of Human Solid Tumors: Basic and Translational Aspects 146
The leukocyte Ig-like receptor (LIR)-1 for the Cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: analysis of LIR-1+ NK cell clones 143
Neuroblastoma-Derived TGF-beta1 Modulates the Chemokine Receptor Repertoire of Human Resting NK Cells. 142
Functional characterization of natural killer cells in type I leukocyte adhesion deficiency 142
Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin 140
Identification of 4Ig-B7-H3 as a novel neuroblastoma-associated molecule that exerts a protective role from natural killer cell-mediated lysis 138
New perspectives in glioma immunotherapy. 138
Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes (LDGL) 137
Neuroblastoma Cells Modulate Chemokine Receptor Repertoire of Resting NK Cells 137
A multi-organ-on-chip to recapitulate the infiltration and the cytotoxic activity of circulating NK cells in 3D matrix-based tumor model 135
Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences on the NK-mediated killing of dendritic cells 133
Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule 133
Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastoma 133
The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition 130
Tumor Microenvironment and Hydrogel-Based 3D Cancer Models for In Vitro Testing Immunotherapies 130
Identification of a novel neuroblastoma-associated molecule that protects from NK-mediated lysis 129
Therapeutic and diagnostic methods and compositions targeting 4IG-B7-H3 and its counterpart NK cell receptor 127
Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants 125
NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. 124
Shaping of adaptive immunity by innate interactions 124
Natural Killer cells recognize and kill human glioblastoma cells with stem cell-like properties 123
Elementi di istologia e cenni di embriologia 121
B7-H3 in Pediatric Tumors: Far beyond Neuroblastoma 115
The SIICA School of Immunology 2017: a gathering for NGS (next generation scientists) 114
ISTOLOGIA di Monesi 7 114
Su.64. Natural Killer Cell-mediated Recognition of Human Brain Tumors 113
Selective cross-talk among natural cytotoxicity receptors in human natural killers cells 108
High-dimensional single-cell analysis of human natural killer cell heterogeneity 104
TGFβ1 inhibits the surface expression of the NKp30 and NKG2D triggering NK receptors: consequences for the NK-mediated killing of dendritic cells 103
Strategies for Potentiating NK-Mediated Neuroblastoma Surveillance in Autologous or HLA-Haploidentical Hematopoietic Stem Cell Transplants 97
Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine /chemokine secretion in CD56(bright) and CD56(dim) NK cells 84
Surface NK receptors and their ligands on tumors cells 84
Inhibitory axes impacting on the activity and fate of Innate Lymphoid Cells 83
NK Cell Function Regulation by TGF-β-Induced Epigenetic Mechanisms 75
Membrane IL-18 identifies a human macrophage subset with distinct proteomic and functional traits 71
Monocyte and Macrophage in Neuroblastoma: Blocking Their Pro-Tumoral Functions and Strengthening Their Crosstalk with Natural Killer Cells 67
miR-24-3p down-regulates the expression of the apoptotic factors FasL and BIM in human natural killer cells 66
Editorial: Recent 3D Tumor Models for Testing Immune-Mediated Therapies 64
Exosomes and immune modulation: implications for neuroblastoma immunotherapy 56
Editorial: TGF-β as a Key Regulator of NK and ILCs Development and Functions 53
Immunomodulatory Mechanisms Impacting the Activity and Fate of Natural Killer Cells in Cancer 38
Natural killer cells and engagers: Powerful weapons against cancer 35
Totale 11.211
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.683
article - articoli 33.927
book - libri 722
conference - conferenze 371
curatela - curatele 0
other - altro 0
patent - brevetti 309
selected - selezionate 0
volume - volumi 354
Totale 71.366
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022818 0 79 66 113 14 53 43 201 38 70 39 102
2022/2023820 81 72 11 85 126 144 3 60 147 6 69 16
2023/2024489 22 69 15 78 29 52 27 38 33 23 43 60
2024/20251.506 25 103 84 91 211 147 176 232 41 67 147 182
2025/20262.815 290 69 170 210 399 213 426 159 247 305 124 203
2026/2027293 292 1 0 0 0 0 0 0 0 0 0 0
Totale 11.211